Detalles de la búsqueda
1.
A retrospective analysis of tolerance and outcomes of cutaneous malignant melanoma in patients receiving adjuvant interferon-alpha 2B: a community oncology perspective.
J Exp Ther Oncol
; 11(2): 91-96, 2017 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-28976130
2.
Tumor molecular profiling in the treatment of refractory cancers.
J Exp Ther Oncol
; 11(1): 27-32, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-26259387
3.
Utility of Lower Extremity Doppler in Patients with Lower Extremity Cellulitis: A Need to Change the Practice?
South Med J
; 108(7): 439-44, 2015 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-26192943
4.
Rare immune-related adverse events in a patient with metastatic melanoma: a case report highlighting sarcoidosis-like reactions triggered by immune-checkpoint inhibitors.
Melanoma Res
; 34(1): 70-75, 2024 02 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37830935
5.
Downregulation of homeobox B8 in attenuating non-small cell lung cancer cell migration and invasion though the epithelial-mesenchymal transition pathway.
Transl Cancer Res
; 13(1): 413-422, 2024 Jan 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-38410214
6.
Complete response of a large basosquamous carcinoma following treatment with cemiplimab and vismodegib.
BMJ Case Rep
; 16(7)2023 Jul 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-37451798
7.
Overexpression of MRPL19 in predicting poor prognosis and promoting the development of lung adenocarcinoma.
Transl Lung Cancer Res
; 12(7): 1517-1538, 2023 Jul 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-37577299
8.
Ipilimumab and nivolumab induced immune-related adverse events in metastatic mucosal melanoma.
BMJ Case Rep
; 14(8)2021 Aug 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-34417242
9.
Does denosumab offer survival benefits? -Our experience with denosumab in metastatic non-small cell lung cancer patients treated with immune-checkpoint inhibitors.
J Thorac Dis
; 13(8): 4668-4677, 2021 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-34527308
10.
Neoadjuvant programmed cell death protein 1 inhibitors combined with chemotherapy in resectable non-small cell lung cancer: an open-label, multicenter, single-arm study.
Transl Lung Cancer Res
; 10(2): 1020-1028, 2021 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-33718040
11.
The association of PD-L1 expression with the efficacy of anti-PD-1/PD-L1 immunotherapy and survival of non-small cell lung cancer patients: a meta-analysis of randomized controlled trials.
Transl Lung Cancer Res
; 8(4): 413-428, 2019 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-31555516
12.
A tertiary care cancer center experience with carboplatin and pemetrexed in combination with pembrolizumab in comparison with carboplatin and pemetrexed alone in non-squamous non-small cell lung cancer.
J Thorac Dis
; 10(6): 3575-3584, 2018 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-30069355
13.
Metastatic uveal melanoma showing durable response to anti-CTLA-4 and anti-PD-1 combination therapy after experiencing progression on anti-PD-1 therapy alone.
J Immunother Cancer
; 6(1): 13, 2018 02 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-29433557
14.
Efficacy of metformin in combination with immune checkpoint inhibitors (anti-PD-1/anti-CTLA-4) in metastatic malignant melanoma.
J Immunother Cancer
; 6(1): 64, 2018 07 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-29966520
15.
Modification of Technique for Suprapubic Catheter Placement After Robot-assisted Radical Prostatectomy Reduces Catheter-associated Complications.
Urology
; 86(2): 401-6, 2015 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-26189333
16.
Spontaneous Regression of Refractory Diffuse Large B-Cell Lymphoma with Improvement in Immune Status with ART in a Patient with HIV: A Case Report and Literature Review.
Am J Case Rep
; 16: 347-52, 2015 Jun 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-26046822
17.
An extended overall survival analysis of pemetrexed and carboplatin with or without pembrolizumab as first-line therapy for advanced non-squamous non-small cell lung cancer.
Ann Transl Med
; 7(Suppl 1): S53, 2019 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-31032332
18.
Osteonecrosis of jaw with the use of denosumab.
J Cancer Res Ther
; 7(4): 499-500, 2011.
Artículo
en Inglés
| MEDLINE | ID: mdl-22269422
Resultados
1 -
18
de 18
1
Próxima >
>>